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Abstract
Emerging and re-emerging zoonotic diseases pose a threat to both humans and animals. This common threat is an
opportunity for human and animal health agencies to coordinate across sectors in a more effective response to zoonotic
diseases. An initial step in the collaborative process is identification of diseases or pathogens of greatest concern so that
limited financial and personnel resources can be effectively focused. Unfortunately, in many countries where zoonotic
diseases pose the greatest risk, surveillance information that clearly defines burden of disease is not available. We have
created a semi-quantitative tool for prioritizing zoonoses in the absence of comprehensive prevalence data. Our tool
requires that human and animal health agency representatives jointly identify criteria (e.g., pandemic potential, human
morbidity or mortality, economic impact) that are locally appropriate for defining a disease as being of concern. The
outcome of this process is a ranked disease list that both human and animal sectors can support for collaborative
surveillance, laboratory capacity enhancement, or other identified activities. The tool is described in a five-step process and
its utility is demonstrated for the reader.
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Introduction
The majority of emerging or reemerging infectious diseases
originate in animals [1,2], with over 250 zoonoses documented in
the literature as newly discovered or rapidly increasing in
incidence or geographical range in the past 70 years [3,4]. In
addition to the emergence of zoonotic pathogens, an estimated
20% of all human illness and death in the least developed
countries are attributable to endemic zoonoses [5]. Globally, the
top 13 zoonoses deemed most impactful to poor livestock keepers
in developing countries are responsible for an estimated 2.7
million deaths and 2.4 billion cases of human illness each year; the
majority of these diseases also have negative effects on livestock
production [4]. The global impact of emerging and endemic
zoonoses on both human and animal populations make their
control and prevention a natural starting point for collaboration
between human and animal health sectors. As collaboration efforts
move forward, identifying zoonotic disease priorities of jurisdic-
tional importance to governments and institutions becomes
critical.
Given the realities of finite fiscal and personnel resources for
both public health and animal health institutions in all countries,
joint prioritization of zoonoses has the potential to benefit both
sectors as efforts are made to conduct efficient and effective
surveillance, develop laboratory capacity, target outbreak re-
sponse, implement disease control strategies, and identify research
activities. However, accomplishing the task of prioritization in a
manner that is transparent and useful for all stakeholders can be
challenging even in the best of situations; the paucity of
quantitative data for decision-making and lack of framework
required for multi-sectoral collaboration can significantly impede
the process. Taking a collaborative approach to the priority-setting
process ensures equal input from stakeholders in both human and
animal health sectors, and ideally results in a ranked list of
zoonoses that can inform joint efforts in areas of overlapping
interest.
Historically recognized methods for prioritization have been
adapted by health officials to identify infectious diseases, of both
public and animal health importance, for national surveillance and
risk-assessment [6–12]; several publications have focused specifi-
cally on the prioritization of zoonoses [13–22]. In general, after
determining the pathogens to be prioritized, the ranking processes
have employed a hybrid of methods to 1) select the criteria used to
define the importance of pathogens, 2) apply weights to individual
criteria, and 3) to score the pathogens within each criterion.
Criteria weights and associated criteria scores are then combined
in some manner to produce the final ranked list of pathogens. The
various methods used for criteria selection and weighting, and the
scoring of pathogens are often described as qualitative, quantita-
tive, or semi-quantitative in nature based on the scoring system
used and the type of data required (Table 1).
Published descriptions of infectious disease prioritization pro-
cesses vary by the number of pathogens ranked, the number of
criteria chosen and the methods used for ranking criteria and
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scoring pathogens (Table 2). Most recent publications have moved
toward using more quantitative methods for prioritization,
however all still rely on subject matter expert (SME) opinion at
some time during the process. Although a few of the recent
publications are focused on prioritization in developing countries
[20–22], efforts overall remain limited to a small subset of health
institutions, particularly to those located in developed countries
with greater access to scientific expertise and specific disease
prevalence data [13–19].
One Health Zoonotic Disease Prioritization Tool
In contrast to existing prioritization processes, the One Health
Zoonotic Disease Prioritization (OHZDP) Tool was developed
specifically to meet the needs of those working in areas where
quantitative data on zoonoses are scarce and ties between the
human and animal health sectors may be underutilized. Using
established qualitative, semi-quantitative and quantitative meth-
ods, the OHZDP Tool seeks to build collaboration between
diverse stakeholders and provide a dynamic list of prioritized
zoonoses that can be used to justify research and allocate funding.
Four important requirements of the prioritization tool were
identified during the development process. Specifically, the Tool
is designed to:
1) Allow equal input from stakeholders in all invested sectors
using transparent methods.
2) Accommodate diversity in location (i.e. globally), scale (i.e.
local, national, regional), and intended purpose (i.e. project
development, surveillance, research activities, etc.) of the
prioritization process.
3) Acknowledge data limitations and utilize alternative disease
data to create a prioritized list of zoonotic diseases when data
specific to the region are not available.
4) Provide outcomes in a timely manner so that participants may
give immediate feedback and capitalize on collaborations built
during the prioritization process.
Methods
The OHZDP Tool addresses the above requirements in a series
of five steps (Figure 1). Some of the steps involve group work,
while others can be performed by a single individual or subset of
the group. The setting in which the group work takes place is
assumed to be in-person, as discussion is key to several steps in the
process. A moderator familiar with the Tool is optimal to facilitate
group discussion and to compile and present results.
In order to provide a clear understanding of the process, an
example of the expected outcome is provided after each step in the
process is described below. The example is not representative of
any specific government or country institution, but is intended to
give the reader an idea of how the process proceeds stepwise.
Step One–Prepare for Group Work
Once the need for joint prioritization is recognized and the
intent for the product of the prioritization process is agreed upon
(i.e. how the prioritized list will be used for collaboration by the
stakeholders), a group of suitable representatives of all stakeholders
is identified and asked to participate. Based on focus group
research, the recommended number of participants should be
between 6 and 12 people in order to balance variation in opinion
with a manageable group size [23,24]; Stakeholder groups should
be equally represented in the final group selection. Selected
representatives should have a strong working knowledge of their
sector’s current zoonotic disease activities and ability to advocate
for the use of the final prioritized list in future collaborative efforts.
With the purpose of the prioritization in mind, a list of zoonoses
of jurisdictional importance to the stakeholders is generated. This
list can be compiled by a single person or group (not necessarily
the selected stakeholder representatives), and should make use of
all available internal and external sources. The list should be
thoughtfully generated and include zoonoses and vector-borne
diseases with animal reservoirs suspected to be of local importance;
rather than an exhaustive enumeration of all possible zoonotic
diseases. The list is brought to the table at the beginning of the
group meeting, and may consist of diseases (e.g. Salmonellosis),
pathogens (e.g. Salmonella enteritidis), and/or groups of pathogens
(e.g. food-borne gastrointestinal illness) depending on the level of
detail desired. Optimally, the list will include about 15–30 diseases
or pathogens.
Example:
N Purpose: To determine which zoonoses will receive funding for
joint surveillance projects between a human health agency and
an animal health agency in ‘Country X’.
N Stakeholders include both the human and animal health
agencies. Each agency chooses five representatives to partic-
ipate in the prioritization process for a total of 10 participants.
N Prior to the scheduled group work, one representative from
both the human and animal health agency work together to
develop the list of zoonoses to be ranked. The list includes: all
zoonotic pathogens currently under surveillance by either the
human or animal health agency; and any zoonoses known to
be present in the human or animal population in Country X or
Table 1. Methods used for criteria selection, weighting and scoring of pathogens.
Method Definition Examples
Qualitative Qualitative methods rely on subjective individual
preference and, in group settings, are often based on
a process that creates consensus among group members
Delphi method [28];
Subject matter expert
opinion
Semi-
quantitative
Semi-quantitative methods also rely on individual
preference, but allow choices to be ranked relative
to each other using a numerical scale
Analytic Hierarchy
Process [25]; Las Vegas
method [29]
Quantitative Quantitative methods rely on numerical scales
that are designed to reflect objective values
(e.g. prevalence or incidence)
Decision Tree Analysis*
[30]
*The nature of the questions used in the decision tree will determine if the process is quantitative or semi-quantitative.
doi:10.1371/journal.pone.0109986.t001
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in any bordering country as determined by a PubMed
literature search, reports to ProMED-mail, the World Health
Organization (WHO) and the World Organisation for Animal
Health (known as OIE for its acronym in French). The list
generated includes 20 zoonoses, all of which are categorized as
individual pathogens except for several bacterial foodborne
zoonoses (Escherichia coli, Salmonella spp., and Campylobacter
spp.,), which are included as a single category of ‘‘Bacterial
Food-Borne Zoonoses’’.
Step Two–Develop the Criteria
The selected group of 6–12 stakeholder representatives meets to
brainstorm and develop a list of criteria that will be used to define
what qualifies a zoonosis as being important. Five to nine criteria
are agreed upon through moderated discussion, but not ranked at
this time. The range in number of criteria [5–9] has been
recognized as optimum for use in the ranking process used in Step
4 of the Tool [25]. The list of criteria is generated by subjective
assessment, however the moderator provides examples of criteria
used in other published methods for disease prioritization to the
group in order to encourage careful consideration of all potentially
useful criteria (Table 3).
Example:
N The ten representatives meet and select the following criteria
(not listed in any specific order) as important to determining
joint surveillance priorities: Bioterrorism potential, severity of
illness in humans, economic burden of disease, amenability to
collaborate, and epidemic potential.
Step Three–Develop a Question for Each Criterion
One categorical question is composed for each criterion using
the same group of representatives. The questions can have
binomial (e.g. yes/no) or multinomial answers that must be ordinal
in nature (e.g. ,10%, 10–50%, .50–75%, .75%). The ordinal
nature of the answers is necessary for the scoring process used in
the decision-tree analysis described in Step 5. Numerical cutoff
values should be selected carefully, as different cut points will alter
scores for some pathogens, and should provide good discrimina-
tion among diseases. In order to simplify the process, no more than
5 ordinal categories are recommended; this is consistent with the
quantitative scales used by previously described methods [15–17].
The Tool provides a list of sample categorical questions for each
of the criteria listed (Table 3), however these can and should be
modified based on group preference and relevance to the
particular purpose of the process. Questions must be structured
in such a way that they can be answered by a single person or
group using data sources available for all of the pathogens on the
initial list. Sources of data to answer the questions are identified or
defined at this point, according to the respective question (e.g.
CDC website, PubMed literature search, country outbreak or
surveillance data, OIE website, WHO website, etc.). Ensuring that
questions are answerable provides the qualitative component of
the prioritization method and may require unique or innovative
thinking during question development, especially in settings where
traditional disease data such as prevalence and incidence are
lacking.
Example:
The ten representatives develop the following questions and
answers to represent criteria selected in Step 2:
N Bioterrorism Potential:
Figure 1. The five steps of the prioritization process using the One Health Zoonotic Disease Prioritization Tool.
doi:10.1371/journal.pone.0109986.g001
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Q: Is the pathogen listed as a select agent (Lists A, B, or C)?
A: Yes or No
Source: As referenced by CDC website.
N Severity of Illness in Humans:
Q: Is the case fatality rate for the pathogen/disease in humans
greater than 10%?
A: Yes or No
Source: As referenced by WHO website or published
literature specific to the country.
Table 3. Example criteria and categorical questions used in Steps 2 and 3 of the OHZDP Tool to prioritize zoonotic diseases (ZD).
Examples of Criteria for Selection*
Examples of Candidate Categorical
Questions Used to Define Each Criteria{
Transmission potential between
humans and animals
Q: Has the ZD caused outbreaks in the country involving animals and humans within the last XX
years?
A: Yes or No
Epidemic/pandemic potential in humans Q: Has the ZD caused epidemics in the past XX years?
A: Yes or No
Q: Has the ZD caused pandemics in the past XX years?
A: Yes or No
Q: Has the ZD pathogen been detected in a new location or population (human or animal) in the
country in the past XX years?
A: Yes or No
Q: Is the ZD pathogen capable of sustained human-to-human transmission?
A1: Yes or No
A2: Three categories: Never reported, Rare/close contact only, Sustained
Bioterrorism potential Q: Is the ZD listed as select agent (Lists A, B, and C)?
A: Yes or No
Amenability to collaborate/collaboration
already established
Q: Do both the Ministry of Health (MoH) and Ministry of Agriculture (MoA) have surveillance/
control measures for the ZD?
A1: Yes or No
A2: Three categories: Neither, Either MoH or MoA, Both MoH and MoA
Economic burden of disease Q: What is the ZD case fatality rate in animals without treatment?
A: Four categories: 0–1%, .1–10%, .10–25%, .25%
Q: Is the ZD listed on the OIE list of reportable animal diseases?
A: Yes or No
Q: Does the ZD cause significant (.XX%) decrease in animal productivity?
A: Yes or No
Severity of illness in humans Q: What is the ZD case fatality rate in humans without treatment?
A: Three categories: 0–1%, .1–10%, .10%
Q: Is the ZD case fatality rate .XX% in humans?
A: Yes or No
Q: Can the ZD result in long-term disability?
A: Yes or No
Q: Is case fatality rate greater than XX%, or does the pathogen cause long-term disability in
greater than XX% of those infected?
A: Yes or No
Ability to prevent/control the zoonotic
disease in the country
Q: Is the ZD listed in country-specific surveillance programs for humans or animals?
A1: Yes or No
A2: Three categories: Neither, human or animal, both human and animal
Q: Is there a known wildlife reservoir for the pathogen?
A: Yes or No
Q: Is there an effective vaccine for the ZD in the primary animal reservoir?
A: Yes or No
*The handout is provided to participants to stimulate conversation and is not intended as an exhaustive list of possibilities.
{Only one categorical question is chosen to represent each criterion.
doi:10.1371/journal.pone.0109986.t003
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N Economic Burden of Disease:
Q: Does the pathogen cause more than 10% mortality in the
animal population or more than a 10% decrease in animal
productivity?
A: Yes or No
Source: As referenced by OIE website or published literature
specific to the country.
N Epidemic Potential:
Q: Has the pathogen been detected in a new location or
population (human or animal) within Country X or any
bordering country within the past 5 years?
A: Yes or No
Source: As referenced by Country X outbreak and/or
surveillance data, confirmed reports on ProMED mail website,
confirmed reports to WHO or OIE.
N Amenability to Collaborate:
Q: Do human or animal health laboratories have diagnostic
capacity available for the pathogen in Country X?
A: Three categories: (Neither) or (At least one- human or
animal) or (Both human and animal labs have capacity)
Source: Confirmation from Country X laboratory personnel
Step Four–Rank the Criteria
The selected criteria are ranked using the semi-quantitative
Analytic Hierarchy Process (AHP) [25]. First, each group member
individually ranks the criteria using a series of pairwise compar-
isons of the criteria with a Microsoft Excel program developed as
part of the OHZDP Tool to help guide participants through the
ranking process. Next, the moderator uses the Excel program to
merge responses of all participants, thus creating a ranked list of
the criteria determined by the scores provided by each individual.
Finally, a sequential (from largest to smallest) weight is assigned for
the highest to lowest ranked criterion (e.g. for five selected criteria,
the highest ranking criterion is assigned a weight of 5, the second
highest a 4, down to the lowest ranking criterion which receives a
weight of 1).
Example:
Each of the ten representatives individually ranks the criteria
developed in Step 2 using the AHP process with the assistance of
the Excel program. The individual scores are combined to
produce a final ranked list of criteria, and are given weights based
on their rank:
1) Severity of Illness in Humans (weight = 5)
2) Bioterrorism Potential (weight = 4)
3) Economic Burden of Disease (weight = 3)
4) Capacity to Collaborate (weight = 2)
5) Epidemic Potential (weight = 1)
Step Five–Rank the Zoonotic Diseases
A decision tree is built in Microsoft Excel using the highest
ranked criterion as the first node, the second highest ranked
criterion as the second node, and so on. The previously formulated
categorical questions and answers delineate the path that diseases
will follow. The pathogens identified in Step 1 move through the
decision tree based on responses to the categorical questions at
each node. Responses or ‘‘decision branches’’ are weighted based
on the weight given to each criterion in Step 4. When answers are
binomial, a score of 1 is applied to one answer and a score of 0 is
given to the other answer. The answer given a ‘1’ will receive the
full weight of the criterion. For questions with multinomial
answers, scores are given in increasing levels determined by
dividing the answer’s ordinal position by the total number of
answers to the question (e.g. A question with 4 ordinal answers:
score for v10%~174~0:25; score for 10{50%~274~0:5;
score for w50{75%~374~0:75; w75%~474~1). The
weight corresponding to the criterion is then multiplied by the
answer’s score to get the weighted score for the question (e.g. if the
answer to the question was 10–50% and the weight of the criterion
was 3, then the weighted score for the question~(274)x3~1:5).
Weighted scores for all questions are summed for each pathogen
and normalized in relation to the maximum score to generate the
final prioritized list of pathogens. The final product is a list of the
original pathogens, presented in a ranked order that is determined
by the weighted criteria deemed important by the group.
Example (Figure 2):
N The question for the first criterion (severity of illness in
humans) has a binomial answer (yes/no); it was decided that
the ‘yes’ answer receives the score of 1. For the example of
rabies, the answer to question 1– ‘‘Is the case fatality rate in
humans greater than 10%?’’– is ‘yes,’ therefore the score of 1 is
multiplied by the weight of the criterion (weight = 5) and the
weighted score = 5. This process is applied to all questions with
binomial answers.
N The question for the fourth criterion (capacity to collaborate)
has a multinomial answer (neither/at least one/both), with
‘neither’ receiving the lowest score (173~0:33), ‘at least one’
receiving the second highest score (273~0:67) and ‘both’
receiving the highest score (373~1). For the example of
rabies, the answer to question 4– ‘‘Do the human or animal
laboratories have diagnostic capacity available for the
pathogen in Country X?’’–is ‘both’, therefore the score of
373 is multiplied by the weight of the criterion (weight = 2),
and the weighted score = 2. If the answer was ‘at least one’
then the weighted score would be ~(273)x4~1:34.
The final score for rabies is 8, or the sum of the weighted scores
for each question(5z0z0z2z1~8). Each of the original 20
zoonoses on the list is scored with this method and the final scores
are normalized in relation to the highest score. After all pathogens
are scored based on the results of decision tree analysis, the
agencies in this fictitious example agree to use available funding to
support the top 5 zoonoses on the ranked list to support joint
surveillance activities.
Discussion
As governments and institutions move toward a multi-sectoral
approach to zoonotic disease prevention, control, and research,
effective channels for collaboration are required. Methods for joint
prioritization can provide the means to open communication and
build trust as well as provide transparency in the priority decision-
making process. The proposed OHZDP Tool provides a process
through which a prioritized list of zoonotic pathogens is generated
by combining a qualitative method for determining criteria to be
used, the semi-quantitative method of the AHP to rank criteria,
and the quantitative technique of decision tree analysis to rank the
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pathogens. The process and methods employed meet the four
requirements that were identified during the development phase.
Equal input from all participants is achieved in steps 2 through
4, combining group discussion and individual ranking to generate
a weighted set of criteria and associated questions to be used in the
decision tree analysis. Although qualitative methods, in this case
group agreement on criteria and questions, have been criticized
for lack of transparency and for the potential introduction of bias
that can occur when employed in group settings [8], the semi-
quantitative method of the AHP used to create the combined
ranked list of criteria ultimately limits the influence any one person
or perspective can have over the decision-making process.
However, decisions made based on qualitative and semi-quanti-
tative methods still rely on the selection of participants who may or
may not be representative of all stakeholders [26,27]; thus, the
appropriate selection and balance of stakeholders is explicitly
emphasized as part of the prioritization process.
The OHZDP Tool provides flexibility to diverse stakeholders
invested at local, national, or regional levels by allowing the group
to first determine the purpose of the prioritization process and
then define criteria and questions relevant for ranking the list of
zoonoses. The example of ‘Country X’ used in this paper defines
its purpose as ‘funding allocation for disease surveillance at the
national level’ and creates a list of all zoonotic pathogens that are
geographically relevant and of national interest. Alternatively, the
Tool could be used by a university or research institution to
determine which zoonotic diseases should be the focus of the
upcoming funding cycle. In this case, the list may be smaller and
limited to the current investigators’ pathogens of interest or
current research.
Strictly quantitative methods provide a more unbiased ap-
proach to decision-making because choices are based on data. For
example, in health decision-making, people can examine health
parameters for different diseases and prioritize them based on
burden of disease estimates, provided good quality data are
available. Quantitative methods have been applied to prioritize
diseases, specifically in developed countries [15–17]. However, the
methods have rarely been employed in developing countries,
where, in general, public health surveillance data are lacking [20–
22]. The OHZDP Tool uses decision tree analysis in a quantitative
manner, relying on the categorical questions to be answerable
based on objective data. Because questions are not fixed as they
are for most other described methods [7,10,13,15–20], this allows
participants to make use of disease data they know to be available
for the scope and purpose of the prioritization process.
Integral components of collaborative work include respect for
time and the ability to act on decisions made by the group.
Although the OHZDP Tool was designed with the desired
outcome of a prioritized list in mind, it also builds collaboration
through the process. By coming together as a group, representa-
tives are able to understand how other stakeholders view the
importance of zoonoses to their relative sectors; developing criteria
together helps to frame the zoonoses in relation to group priorities.
The OHZDP Tool provides Microsoft Excel programs to assist in
group ranking of criteria (Step 2) and in the final ranking of
pathogens in the decision tree process (Step 5), which together with
Figure 2. An example of decision tree analysis (Step 5 in the OHZDP Tool) for rabies. The criteria and questions shown are examples only,
provided to show the process of how each zoonotic disease is scored. Criteria and questions are developed and given weights by the stakeholder
representatives during the facilitated group work in Steps 2–5. Weighted scores for each question are summed to give the total weighted score for
each pathogen; total weighted scores are normalized in relation to the maximum pathogen score to give a final ranked list.
doi:10.1371/journal.pone.0109986.g002
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facilitated group work results in a rapid and transparent method
for zoonoses prioritization.
In the pilot trials of the tool, Steps 2–4 could be completed in a
one-day time period. The decision tree process, which can be
completed primarily by the facilitator or other assigned individ-
uals, can take up to another half or full day of time depending on
the number of zoonoses selected for analysis. This means that
participants know the results of the ranked criteria at the end of
the first group session, and the results for the final ranked pathogen
list can be ready within 24 hours. Rapid turnaround allows further
discussion and a timely output that can be used immediately for its
intended purpose.
To provide further clarification for the five steps in the OHZDP
Tool, the complete output from one pilot study is provided in the
supporting information. For this particular pilot study, the authors
brought together six professionals currently active in zoonotic
disease research. Three of the participants were asked to assume
the role of representatives from a fictional country’s Ministry of
Health and three from the Ministry of Agriculture. They were
provided a list of 17 zoonoses (Table S1) and assisted through
Steps 2–4 of the OHZDP Tool (Tables S2, S3). Step 5 was
completed by the authors (Table S4, S5), and the final prioritized
list is presented in Table S6.
The authors are aware that further validation of the OHZDP
Tool is an optimal next step; however, the OHZDP Tool is similar
to other tools in its design, as each step of the prioritization process
(selection of criteria, weighting of criteria, scoring of pathogens,
and final determination of pathogen rank), employs a previously
validated prioritization method (Table 2). Quantitative compari-
son with the tools that already exist may be difficult as the majority
require at least basic surveillance data [7,10,15–19]. The OHZDP
Tool is designed to be used in countries where surveillance data
are lacking and even expert opinion may not be sufficient to
accurately estimate zoonotic disease prevalence or incidence in
human and/or animal populations.
Future pilots of the Tool will assess its internal validity by
repeating the process using different representatives from the same
stakeholder groups and comparing the final prioritized lists using
non-parametric tests. In addition, results of sensitivity tests for the
impact of each criterion and the importance of assigned criteria
weights will be documented to assess their influence on the final
ranking of the diseases. And finally, although the range of number
of participants, criteria and categories for questions were provided
using documented sources [23–25], the robustness of the Tool can
be further evaluated by altering these values and comparing
results. A Facilitator Manual for the OHZDP Tool, including
instructions for the Excel programs is available from the authors
upon request for those interested in participating in ongoing
evaluation and validation of the Tool.
In summary, the OHZDP Tool was developed for use by
organizations or institutions interested in prioritizing zoonoses; the
purpose of the prioritization can vary based on stakeholder needs,
but can ultimately serve to identify areas of overlapping interest,
focus the use of limited resources, and maximize the impact of
zoonotic disease related activities. The Tool presented here differs
from others in its ability to combine individual and group decision
making processes together with limited disease data in a manner
that is flexible enough to meet the needs of multi-sectoral groups
with differing levels of jurisdictional reach. The authors feel the
tool offers a transparent and timely process for those who wish to
prioritize zoonoses using a collaborative approach and welcome
any questions or comments on the Tool’s potential utility.
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